← Evidence map

ArticleScience advances2025

Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors.

Yue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40632862